The short answer
Evaluation may include tissue biopsy, immunophenotyping, cyclin D1 or related molecular assessment, imaging, blood tests, and selected marrow or gastrointestinal evaluation. Each result should answer a specific diagnostic, risk, or treatment question.
Evaluation may include tissue biopsy, immunophenotyping, cyclin D1 or related molecular assessment, imaging, blood tests, and selected marrow or gastrointestinal evaluation.
Planning may depend on disease extent, symptoms, biology and risk, age, fitness, organ function, prior treatment, and goals.
A result can be diagnostic, prognostic, predictive, or useful for monitoring—and these are not identical roles.
Ask which results are confirmed and which remain pending.
Choose how you want to understand this
The full explanation.
What the biopsy shows
Mantle cell lymphoma is diagnosed from a lymph-node or tissue biopsy. A hematopathologist reviews it. This is a specialist in blood and lymph tissue disease. Two markers confirm it: the cells are usually positive for CD5 and CD20, and, most importantly, positive for a protein called cyclin D1.
The genetic change behind it
More than 95% of cases carry a specific translocation. Chromosomes 11 and 14 swap pieces. Doctors write this as t(11;14). This causes the cell to overproduce cyclin D1, which pushes cells to divide when they should not. Finding this change is close to a defining feature of the disease, and it is usually confirmed with a test called FISH.
Why SOX11 and Ki-67 matter
Your report may also mention SOX11, a protein that splits mantle cell lymphoma into two behavior patterns. Low or negative SOX11 (under 10%) is linked to a more indolent, slower course. High SOX11 (10% or more) is linked to a more aggressive course. Ki-67 measures what percentage of cells are actively dividing; a higher percentage generally points to faster growth. These findings feed into a risk score. So do your age, fitness, tumor size, an enzyme called LDH, and TP53 gene status. Your team uses this score for planning.
How results connect to treatment
For younger, fit patients, treatment often starts with intensive chemotherapy. This may include a high dose of a drug called cytarabine, sometimes as part of a regimen called R-DHAP. Rituximab maintenance for two to three years usually follows. Older or less fit patients may start with bendamustine plus rituximab, or R-CHOP.
Autologous stem cell transplant has long been standard after the first round of chemotherapy. In this procedure, your own blood-forming cells are collected, then given back after high-dose treatment. Newer evidence suggests that adding a BTK inhibitor, a pill that blocks a growth signal the cancer depends on, can sometimes achieve similar results without transplant. BTK inhibitors used in mantle cell lymphoma include ibrutinib, acalabrutinib, zanubrutinib, and pirtobrutinib.
If the lymphoma comes back, options include venetoclax, a drug that blocks a survival protein called BCL2. Another option is CAR T-cell therapy, using a product called brexucabtagene autoleucel. This reprograms your own immune cells to attack the lymphoma.
Maintenance therapy after induction
For most people, rituximab maintenance for two to three years after initial treatment is now standard. Studies show it improves how long the disease stays controlled and can improve overall survival. Ask whether maintenance is planned for you and for how long.
What to ask your team
- Was the t(11;14) translocation and cyclin D1 confirmed on my biopsy?
- What is my SOX11 result, and does it suggest a slower or faster course?
- Am I a candidate for intensive chemotherapy and transplant, or a gentler approach?
- Is rituximab maintenance planned, and for how long?
- What would change if TP53 is abnormal?
Sources
Words to know
Tap any term to see what it means.
Common questions
Why are so many tests needed?
Blood cancers can look similar while differing in cell type, biology, pace, and treatment response.
Does one gene result determine treatment?
Usually not by itself. The team interprets it with the full diagnosis, disease status, health, and treatment goals.
What is measurable residual disease?
It is sensitive testing for disease remaining after treatment; its meaning and use vary by blood cancer and test.
Can results be reviewed elsewhere?
You can ask whether specialist hematopathology review would increase confidence or change planning.
Questions to ask your doctor
Being prepared helps you get the most out of your appointments. Save or print these questions.
Tap a question to save it to your list (kept on this device).
Your next step
Turn this guide into a short list for your care team.
Speak With Trained Specialists & Human Navigators
Cancer Explained provides educational guidance, but does not replace trained specialists, social workers, or your medical team.
Talk to a trained cancer information specialist
Free, confidential assistance from NCI Cancer Information Service via phone, chat, or email.
Contact your oncology team
Locate after-hours contact numbers, portal messages, or urgent triage phone lines.
Find a patient navigator
Get one-on-one help with appointments, logistics, translation, and care coordination.
Find a genetic counselor
Discuss inherited mutation risk, family history, and genetic testing options.
Find an oncology social worker
Access emotional counseling, family support groups, and mental health resources.
Find a financial navigator
Locate copay assistance foundations, grant programs, and lodging/travel support.
Find a clinical-trial specialist
Search matching studies and speak with NCI trial information specialists.
Get urgent help
Immediate emergency guidance for fever (>100.4°F during chemo), severe pain, or shortness of breath.
Help Us Improve This Guide
Did this explanation answer your question and help you determine your next step?
Know someone who needs this?
Plenty of people are looking for something like this and do not know where to start. If this would help a friend or someone you love, send it on — we have written an opening line so you do not have to stare at an empty message. You can change every word of it.
Your message is written and sent in your own email or messaging app — we never see who you send it to, and nothing is added to any list.
Plain-language explanation of the published sources cited on this page. AI-assisted, source-checked, not clinician-reviewed.
Sources last checked: 2026-07-22 what this meansLast updated: 2026-08-05Next planned review: 2027-07-22
How this page was created
Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes. We do not employ clinicians and do not intend to — our work is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.
Editorial status — Source checked. This page was written with AI assistance and checked line by line against the sources listed on it. That confirms the sources support what the page says. It is not a medical review, and it does not confirm the page is complete or right for your situation.
General education — varies by person. Answers genuinely differ between people. This page explains what commonly varies and points you to your care team for your situation.
Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.
How this page was created
Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes. We do not employ clinicians and do not intend to — our work is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.
Editorial status: Source checked — This page was written with AI assistance and checked line by line against the sources listed on it. That confirms the sources support what the page says. It is not a medical review, and it does not confirm the page is complete or right for your situation.
Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.
Read more about our editorial process, our use of AI, and our corrections policy.
Spotted a problem? Report an error — a factual mistake, broken or outdated source, confusing wording, or anything that seems unsafe. Please do not include names, medical record numbers, dates of birth, addresses, or other identifying medical information in your report.
After using this page, do you understand what to do next?
Anonymous — we only record the answer, never who gave it.
Related articles
Still have questions?
Educational answers, plain language
Free to print and share